Resmed Inc
NYSE:RMD

Watchlist Manager
Resmed Inc Logo
Resmed Inc
NYSE:RMD
Watchlist
Price: 243.09 USD -0.66% Market Closed
Market Cap: 35.6B USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one RMD stock under the Base Case scenario is 222.66 USD. Compared to the current market price of 243.09 USD, Resmed Inc is Overvalued by 8%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RMD Relative Value
Base Case
222.66 USD
Overvaluation 8%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

7.2
P/S
P/S
Price to Sales
7.2
vs History
69
vs Industry
20
Median 3Y
7.4
Median 5Y
8.1
Industry
2.2
Forward
6.9
More Details
27.3
P/E
P/E
Price to Earnings
27.3
vs History
85
vs Industry
22
Median 3Y
32.7
Median 5Y
38.6
Industry
21.9
Forward
25.5
More Details
21.6
P/OCF
P/OCF
Price to OCF
21.6
vs History
93
vs Industry
17
Median 3Y
26.2
Median 5Y
34.2
Industry
13.5
More Details
29.3
P/FCFE
P/FCFE
Price to FCFE
29.3
vs History
76
vs Industry
11
Median 3Y
55
Median 5Y
60.7
Industry
19.3
More Details
6.4
P/B
P/B
Price to Book Value
6.4
vs History
77
vs Industry
11
Median 3Y
6.9
Median 5Y
8.8
Industry
2.1
More Details
7.1
EV/S
EV/S
Enterprise Value to Sales
7.1
vs History
71
vs Industry
18
Median 3Y
7.5
Median 5Y
8.3
Industry
2.3
Forward
6.9
More Details
12
EV/GP
EV/GP
Enterprise Value to Gross Profit
12
vs History
76
vs Industry
18
Median 3Y
13
Median 5Y
14.7
Industry
4.8
More Details
19.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
19.6
vs History
77
vs Industry
18
Median 3Y
21.9
Median 5Y
25.9
Industry
11.5
Forward
18.8
More Details
22
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
22
vs History
79
vs Industry
21
Median 3Y
25.4
Median 5Y
30.5
Industry
15.6
Forward
20.4
More Details
21.4
EV/OCF
EV/OCF
Enterprise Value to OCF
21.4
vs History
93
vs Industry
17
Median 3Y
26.8
Median 5Y
35.1
Industry
13.3
More Details
22.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
22.7
vs History
93
vs Industry
19
Median 3Y
30.8
Median 5Y
41.2
Industry
17.3
More Details
5.5
EV/IC
EV/IC
Enterprise Value to IC
5.5
vs History
55
vs Industry
15
Median 3Y
5.3
Median 5Y
5.7
Industry
1.8
More Details

Multiples Across Competitors

RMD Competitors Multiples
Resmed Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Resmed Inc
NYSE:RMD
35.7B USD 7.2 27.3 19.6 22
US
Abbott Laboratories
NYSE:ABT
232.6B USD 5.5 17.2 22.4 32.1
US
Intuitive Surgical Inc
NASDAQ:ISRG
193.1B USD 22.2 78 62.3 75
US
Boston Scientific Corp
NYSE:BSX
154.2B USD 8.7 74.9 35.7 49.6
US
Stryker Corp
NYSE:SYK
147B USD 6.3 51.4 25.4 30.6
IE
Medtronic PLC
NYSE:MDT
107.6B USD 3.2 25.3 13.5 19.1
DE
Siemens Healthineers AG
XETRA:SHL
52B EUR 2.3 26.2 15.2 21.6
US
Becton Dickinson and Co
NYSE:BDX
48.5B USD 2.3 31.9 12.9 24
US
Edwards Lifesciences Corp
NYSE:EW
44.3B USD 8 10.6 24.2 26.7
US
IDEXX Laboratories Inc
NASDAQ:IDXX
39.6B USD 10.1 44.2 31.4 35.1
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
273.8B CNY 7.7 24.6 21.5 21.5

See Also

Summary
RMD intrinsic value, competitors valuation, and company profile.
DCF Valuation
RMD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RMD stock valuation using valuation multiples.
Wall Street Estimates
RMD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RMD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 253,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.